“This trial provides, for the first time, evidence that CBD taken at a relatively high dose can reduce self-reported pain intensity in individuals with chronic neuropathic pain.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
The FDA’s decision follows the results of a Phase 3 clinical trial concluding that patients who consumed the cannabis extract experienced greater mean pain reductions than did those who took opioids.
“This legislation modernizes Illinois’ cannabis regulation by bringing the much-needed reforms that patients, consumers, and industry have been asking for.”
Statewide polling reports that 63 percent of Massachusetts’ voters, including majorities of Democrats and Independents, oppose the ballot question.
“The sustained efficacy of cannabis-based medicinal products positions them as a favorable analgesic option compared with opioids.”
“While previous studies have suggested fentanyl co-occurrence in other illicit drugs such as heroin, this study finds no evidence of widespread fentanyl contamination in illicit cannabis.”
The proposed 2027 fiscal year budget seeks to increase the sales tax rate on medical cannabis products from six percent to 10.25 percent.
Nearly 20,000 Iowans are registered to access cannabis extract products.